• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G124
Device Problems Signal Artifact/Noise (1036); High impedance (1291); Over-Sensing (1438); Defibrillation/Stimulation Problem (1573); High Capture Threshold (3266)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/21/2023
Event Type  malfunction  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded an alert for anti-tachycardia pacing (atp) therapy delivered to convert arrhythmia.It was then determined that the atp therapy was appropriate.Far-field r-wave oversensing was observed throughout the episode, resulting in incorrect rhythm classification and possible delay to therapy.The right ventricular (rv) lead pacing impedance was also noted to have increased, however, it remains within normal range.In-clinic assessment was recommended.The crt-d system remains in service.No adverse patient effects were reported.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded an alert for anti-tachycardia pacing (atp) therapy delivered to convert arrhythmia.It was then determined that the atp therapy was appropriate.Far-field r-wave oversensing was observed throughout the episode, resulting in incorrect rhythm classification and possible delay to therapy.The right ventricular (rv) lead pacing impedance was also noted to have increased, however, it remains within normal range.In-clinic assessment was recommended.Additional information was provided.Further changes in the rv lead impedance show an increase to a maximum of 1328 ohms, which is high out of range.A recent increase in the rv capture threshold was also observed.The rv electrogram (egm) baseline seems slightly noisy but there is no oversensing observed in any egm.Ts recommended to continue to monitor.The crt-d system remains in service.No adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17666904
MDR Text Key322540581
Report Number2124215-2023-47318
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/31/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberG124
Device Catalogue NumberG124
Device Lot Number513598
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/07/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age88 YR
-
-